CBP-4888 Use to tREat PreEclampsia (CUREPE-01) An open-label, dose finding study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending subcutaneous doses of CBP-4888 in hospitalized participants with preterm preeclampsia receiving standard of care, expectant management.